Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …

In contrast to the multiple disease-modifying therapies that are available for relapsing–
remitting multiple sclerosis (MS), the therapeutic options for progressive MS (PMS) are …

The role traditionally assigned to astrocytes in the pathogenesis of multiple sclerosis (MS)
lesions has been the formation of the glial scar once inflammation has subsided. Astrocytes …

Experimental autoimmune encephalomyelitis (EAE) is the most commonly used
experimental model for the human inflammatory demyelinating disease, multiple sclerosis …

Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease of the
central nervous system. It affects approximately 400,000 people in the United States and …

Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the central nervous
system. The inflammation is driven significantly by autoreactive lymphocytes, which recruit …

Impact of Diagnosis and Early Treatment on the Course of Multiple Sclerosis Page 1 VOL. 19, NO.
17 ■ THE AMERICAN JOURNAL OF MANAGED CARE ■ S321 Multiple sclerosis (MS), a …

Multiple sclerosis (MS) is a central nervous system chronic inflammatory disease that is
characterized by an extensive and complex immune response. Scientific advances have …

Teriflunomide for multiple sclerosis - He, D - 2016 | Cochrane Library Skip to Content
Cookies Our site uses cookies to improve your experience. You can find out more about our …

The body's immune system is essential for protecting it from a variety of pathogens and other
external insults. It is through the complex interactions between the cells and mediators of …